English EN
What purity tests matter for pharmaceutical gelatin?
Beyond Biopharma | Pharmaceutical Gelatin FAQ
Short answer: The purity tests that matter for pharmaceutical gelatin control process residues and trace contaminants: sulphur dioxide (SO2) from processing, heavy metals and arsenic from raw materials or process, chromium where the monograph requires it, and ash or sulphated ash as a measure of mineral residue, alongside identification tests. All are run to the methods of the current applicable pharmacopoeia and reported on the certificate of analysis.
What the purity section of a monograph controls
Purity testing for a pharmaceutical excipient exists to prove that the material is what it claims to be, and that residues from the raw material or the manufacturing process stay inside defined limits. For gelatin, which starts as animal skin and bone and passes through acid, alkaline, washing and drying steps, the tests of interest are the ones that catch processing chemicals and trace elements. Limits come from the current pharmacopoeia monograph that governs the product, so they should be read from that text rather than from memory.
The main purity tests and what they mean
| Test | What it controls |
|---|---|
| Sulphur dioxide (SO2) | Residue of sulphite treatment used in some gelatin processes; limited because of sensitivity and residue concerns |
| Heavy metals | Trace elements such as lead that can come from raw materials, water or equipment |
| Arsenic | A specific trace element controlled in pharmacopoeia monographs |
| Chromium | Checked where the current monograph requires it, reflecting certain process routes or raw-material risks |
| Ash or sulphated ash | Total mineral residue left after ignition; a general indicator of inorganic contamination |
| Identification (including nitrogen content) | Confirms the material is gelatin of the declared type, with the expected protein basis |
Where the results appear
On a certificate of analysis each purity test is shown either as a numeric result with its limit or as a 'conforms' statement where the monograph sets the acceptance criterion. The certificate should also state the method and, ideally, the pharmacopoeia edition used, because methods and limits move between revisions. A result without a method reference is much harder to defend in an audit, so treat method documentation as part of the result.
What to check before you accept a batch
- Match the agreed specification - confirm each result or 'conforms' line against the range in your purchase specification, not against a brochure.
- Check the monograph and edition - a COA written against an old edition may not satisfy the current one for your market.
- Request the right certificate - if you must meet USP-NF, EP or JP, ask the supplier for results generated against that monograph.
- Protect the sample - contamination during sampling or storage would make a clean certificate misleading, so handle the batch properly between receipt and use.
Purity and microbiology are separate reviews
Purity tests cover chemical residues and mineral content; microbiological tests cover viable organisms. A certificate must be read across both sections, because a material can be chemically pure yet carry a bioburden problem, or clean microbiologically yet exceed a residue limit. Treat the two as independent checks that together support release.
Related reading
See also what microbial limits apply to pharmaceutical gelatin, how to read a pharmaceutical gelatin specification (COA) and how pharmacopoeia compliance is tested.
